ClinicalTrials.Veeva

Menu

Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches

O

Ottawa Hospital Research Institute

Status

Enrolling

Conditions

Arthroplasty, Replacement, Hip

Treatments

Procedure: Direct Anterior Approach (DAA)
Procedure: SuperPATH

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03746925
SuperPATH

Details and patient eligibility

About

This study involves comparing the outcomes after using the Direct Anterior Approach (DAA) and the Supercapsular Percutaneously Assisted Total Hip (SuperPATH) approach. These are two approaches to hip replacement that both replace hips without cutting any muscles. DAA approach has been used for many years, but it has a high learning curve and can be difficult for doctors to use, it is however linked with fewer complications when performed by an experienced doctor. SuperPATH is a newer technique which has been shown in studies to be adopted with less complications even during the learning phase. It also shows cost-saving results, showing a reduced length of stay for patients and better 30-day readmission rates. There is pressure on surgeons, from both patients and administration to use techniques that spare tissue, offer early functionality without compromising long-term outcomes. The SuperPATH can meet this benchmark but uptake has been slow, the investigators believe that it is due to the learning curve shown by this approach. The senior surgeon at The Ottawa Hospital is experienced in both techniques, using a trial the investigators can compare the two techniques and help encourage surgeons to change to a procedure that has demonstrated a low complication profile.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing unilateral THA
  • Over 18 years of age and below 80
  • Subject is willing and able to complete required study visits and assessments
  • Subject is willing to sign the approved informed consent form

Exclusion criteria

  • Subject has both a body mass index (BMI) and waist circumference measurements greater than 35.0kg/m2 and 102.0cm, respectively for men, and 35.0kg/m2 and 88.0cm, respectively for women at screening
  • Subject is currently enrolled in another clinical investigation related to lower limbs, which could affect the endpoints of this protocol
  • Subject has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study
  • Subject is currently incarcerated or has impending incarceration
  • Previous hip surgery or infection on ipsilateral hip

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

Direct Anterior Approach (DAA)
Active Comparator group
Description:
Direct Anterior Approach surgery to replace the hip.
Treatment:
Procedure: Direct Anterior Approach (DAA)
SuperPATH
Experimental group
Description:
SuperPATH approach surgery to replace the hip.
Treatment:
Procedure: SuperPATH

Trial contacts and locations

1

Loading...

Central trial contact

Meaghan Dufresne; Wade Gofton, MD, FRCSC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems